[Hepatitis C and alcohol, which is the limit?]

Area of Science:

• Hepatology
• Gastroenterology
• Viral Hepatitis Research

Background:

• Chronic hepatitis C infection is a significant cause of liver disease, potentially leading to cirrhosis in 20-30% of cases.
• Hepatocellular carcinoma (HCC) is a serious complication, developing in 1-5% of individuals with chronic hepatitis C.
• Alcohol consumption is recognized as a critical factor influencing fibrosis, cirrhosis, and HCC development in hepatitis C patients.

Purpose of the Study:

• To examine the impact of alcohol consumption on the natural course of chronic hepatitis C.
• To investigate the influence of alcohol on the efficacy of antiviral therapy for hepatitis C.
• To clarify the threshold of alcohol intake that poses a risk for disease progression and treatment outcomes.

Main Methods:

• Review of epidemiological studies on alcohol consumption and chronic hepatitis C.
• Analysis of factors affecting treatment response to pegylated interferon and ribavirine.
• Assessment of the role of alcohol in fibrosis, cirrhosis, and hepatocellular carcinoma development.

Main Results:

• High alcohol consumption is associated with an increased risk of fibrosis, cirrhosis, and HCC.
• Factors reducing treatment response to pegylated interferon and ribavirine include high viral load, specific genotypes, sex, and alcohol consumption.
• The precise level of alcohol consumption that becomes detrimental is not well-defined.

Conclusions:

• Alcohol consumption is a significant risk factor in chronic hepatitis C, affecting both disease progression and treatment outcomes.
• While avoiding high alcohol intake (above 40-50 g/day) and recommending a 6-month abstinence before therapy are suggested, further research is needed to establish definitive guidelines.
• More studies are required to fully understand the complex relationship between alcohol consumption and chronic hepatitis C management.